UBS Maintains a 'Neutral' on Seattle Genetics (SGEN); What We Learned from the 1Q11 Call
Tweet Send to a Friend
UBS maintains a 'Neutral' on Seattle Genetics (NASDAQ: SGEN), PT increased from $16.50 to $17.
UBS analyst says, "With the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "With the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
